Stage IB Lung Non-Small Cell Carcinoma AJCC v7

6 clinical trials · Condition

Record	Firm	Date
Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer (NCT03158129)	M.D. Anderson Cancer Center	2017-06-16
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (NCT02595944)	National Cancer Institute (NCI)	2016-07-22
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) (NCT02193282)	National Cancer Institute (NCI)	2015-02-11
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) (NCT02194738)	National Cancer Institute (NCI)	2014-09-26
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery (NCT00324805)	National Cancer Institute (NCI)	2007-07-19
Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery (NCT00254384)	M.D. Anderson Cancer Center	2005-10-05

Every clearance here is in the API, with alerts when new ones post.